M&A Deal Summary

Ajinomoto Cambrooke Acquires Nualtra

On December 21, 2020, Ajinomoto Cambrooke acquired life science company Nualtra

Acquisition Highlights
  • This is Ajinomoto Cambrooke’s 1st transaction in the Life Science sector.
  • This is Ajinomoto Cambrooke’s 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2020-12-21
Target Nualtra
Sector Life Science
Buyer(s) Ajinomoto Cambrooke
Deal Type Add-on Acquisition

Target

Nualtra

Tewkesbury, United Kingdom
Nualtra Ltd. develops and provides medical foods to public health systems for the treatment of patients with disease-related malnutrition. Nualtra is based in Tewkesbury, United Kingdom.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Ajinomoto Cambrooke

Ayer, Massachusetts, United States

Category Company
Founded 2000
Sector Life Science
DESCRIPTION

Ajinomoto Cambrooke, Inc. is a therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are today focused on inborn errors of metabolism and intractable epilepsy.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2020 M&A 1 of 1